![Tony Yao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tony Yao
Gestionnaire de Portefeuille-Actions chez
ArrowMark Colorado Holdings LLC
Profil
Dr. Tony Yao is a Portfolio Manager at ArrowMark Colorado Holdings LLC.
He is the Portfolio Manager for ArrowMark’s life science strategy.
He graduated magna cum laude from Brown University with a bachelor’s degree in Biochemistry and earned both an M.D.
and Ph.D.
in Immunology from Stanford University.
Postes actifs de Tony Yao
| Sociétés | Poste | Début |
|---|---|---|
ArrowMark Colorado Holdings LLC
 ArrowMark Colorado Holdings LLC Investment ManagersFinance ArrowMark uses fundamental research and an opportunistic investment philosophy when investing. They focus on niche and less efficient market segments in public and private credit and equity, leveraged loans, and middle-market commercial real estate finance. The firm primarily invests for relatively long-time horizons, often for a year or more. | Gestionnaire de Portefeuille-Actions | 01/04/2012 |
Arrowmark Partners
 Arrowmark Partners Investment ManagersFinance ArrowMark Colorado Holdings /Private Equity/ seeks investment in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and growth stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Tony Yao
| Sociétés | Poste | Fin |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Directeur/Membre du Conseil | 10/05/2021 |
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Analyst-Equity | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Tony Yao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Janus Henderson Investors US LLC
Janus Henderson Investors US LLC Investment ManagersFinance JHIUS offers US equity, global and international equity, fixed income, asset allocation and alternative investment strategies, including long-short portfolios. For their fundamental investment strategies, the firm seeks to add value versus benchmarks by actively pursuing alpha generation through their own intensive fundamental research. They utilize two complementary processes: a top-down macro analysis and a bottom-up risk/reward analysis. | Finance |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArrowMark Colorado Holdings LLC
ArrowMark Colorado Holdings LLC Investment ManagersFinance ArrowMark uses fundamental research and an opportunistic investment philosophy when investing. They focus on niche and less efficient market segments in public and private credit and equity, leveraged loans, and middle-market commercial real estate finance. The firm primarily invests for relatively long-time horizons, often for a year or more. | Finance |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Arrowmark Partners
Arrowmark Partners Investment ManagersFinance ArrowMark Colorado Holdings /Private Equity/ seeks investment in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and growth stage capital requirements. | Finance |
